<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Choi E</submitter><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>pkae072</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11410193</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Recent therapeutic advances have improved survival among lung cancer (LC) patients, who are now at high risk of second primary lung cancer (SPLC). Hispanics comprise the largest minority in the United States, who have shown a lower LC incidence and mortality than other races, and yet their SPLC risk is poorly understood. We quantified the SPLC incidence patterns among Hispanics vs other races.&lt;h4>Methods&lt;/h4>We used data from the Multiethnic Cohort, a population-based cohort of 5 races (African American, Japanese American, Hispanic, Native Hawaiian, and White), recruited between 1993 and 1996 and followed through 2017. We identified patients diagnosed with initial primary lung cancer (IPLC) and SPLC via linkage to Surveillance, Epidemiology, and End Results registries. W</pubmed_abstract><journal>JNCI cancer spectrum</journal><pubmed_title>Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors.</pubmed_title><pmcid>PMC11410193</pmcid><funding_grant_id>R37 CA226081</funding_grant_id><funding_grant_id>1R01CA282793</funding_grant_id><funding_grant_id>R01 CA282793</funding_grant_id><pubmed_authors>Hua Y</pubmed_authors><pubmed_authors>Liang SY</pubmed_authors><pubmed_authors>Neal JW</pubmed_authors><pubmed_authors>Choi E</pubmed_authors><pubmed_authors>Haiman C</pubmed_authors><pubmed_authors>Leung AN</pubmed_authors><pubmed_authors>Backhus LM</pubmed_authors><pubmed_authors>Han SS</pubmed_authors><pubmed_authors>Wakelee HA</pubmed_authors><pubmed_authors>Le Marchand L</pubmed_authors><pubmed_authors>Wu JT</pubmed_authors><pubmed_authors>Su CC</pubmed_authors><pubmed_authors>Cheng I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Racial and ethnic differences in second primary lung cancer risk among lung cancer survivors.</name><description>&lt;h4>Background&lt;/h4>Recent therapeutic advances have improved survival among lung cancer (LC) patients, who are now at high risk of second primary lung cancer (SPLC). Hispanics comprise the largest minority in the United States, who have shown a lower LC incidence and mortality than other races, and yet their SPLC risk is poorly understood. We quantified the SPLC incidence patterns among Hispanics vs other races.&lt;h4>Methods&lt;/h4>We used data from the Multiethnic Cohort, a population-based cohort of 5 races (African American, Japanese American, Hispanic, Native Hawaiian, and White), recruited between 1993 and 1996 and followed through 2017. We identified patients diagnosed with initial primary lung cancer (IPLC) and SPLC via linkage to Surveillance, Epidemiology, and End Results registries. W</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-03-17T16:14:01.453Z</modification><creation>2025-04-04T01:54:31.693Z</creation></dates><accession>S-EPMC11410193</accession><cross_references><pubmed>39186009</pubmed><doi>10.1093/jncics/pkae072</doi></cross_references></HashMap>